CD20 POSITIVE
Clinical trials for CD20 POSITIVE explained in plain language.
Never miss a new study
Get alerted when new CD20 POSITIVE trials appear
Sign up with your email to follow new studies for CD20 POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising combo tackles tough blood cancer
Disease control OngoingThis study tests a combination of two drugs, ibrutinib and rituximab, in people with mantle cell lymphoma that has come back or not responded to treatment, or in older adults newly diagnosed with the disease. The goal is to shrink tumors and control the cancer. About 113 particip…
Matched conditions: CD20 POSITIVE
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 09:28 UTC
-
Engineered immune cells take aim at Tough-to-Treat blood cancers
Disease control OngoingThis early-stage trial is testing a new type of immunotherapy for people with certain blood cancers (like lymphoma and leukemia) that have returned or not responded to standard treatments. The therapy uses a patient's own immune cells, which are modified in a lab to better recogn…
Matched conditions: CD20 POSITIVE
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New cocktail shows promise for Tough-to-Treat lymphoma
Disease control OngoingThis study tested a new combination of drugs (carfilzomib plus standard chemotherapy) in 29 adults with diffuse large B-cell lymphoma that returned or didn't respond to prior treatment. The goal was to find the best dose and see how well it shrinks tumors. The approach aims to im…
Matched conditions: CD20 POSITIVE
Phase: PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 20, 2026 11:53 UTC